SurgicEye congratulates its partners Crystal Photonics GmbH and the Interventional Molecular Imaging laboratory at LUMC for the CE-certification and market introduction of the world first re-sterilizable DROP-IN gamma probe. This new product will enable to port radio-guided surgery to the robotic setup, thus marking a breakthrough in personalized surgery. We look forward to cooperating further with them in this great journey. We are looking forward to integrate the Drop-In probe into our declipse®SPECT framework for further indications. If you are interested in the DROP-IN gamma probe, contact us directly at email@example.com.
SurgicEye and Crystal Photonics show their solutions for radio guided surgery at EANM (joint booth number 001). The offered products go from gamma probes providing acoustic feedback to 3D imaging and navigation as provided by the declipse®SPECT device. All devices will be on the booth and you could get hands-on sessions with the team from both companies. We are looking forward seeing you soon.
What clinicians say
- Prof. Dr. René HornungHead of Department of Gynecology Kantonsspital St. Gallen, SwitzerlandThe 3D declipse®SPECT Laparoscopy technology opens new horizons to minimally invasive surgery in gynecologic oncology. Sentinel lymph node biopsy during laparoscopic procedures seems to be easily feasible and may in the near future become standard of care for cervical and endometrial cancers.
- Dr. Sergi Vidal SicartNuclear Medicine Specialist, Hospital Clínic Barcelona, SpainThe 3D declipseSPECT presents a potential tool in refining the excision margins of tumor in the ROLL technique. The possibility to observe the harvested tissue and the tracer activity within it offers a realistic view of the surgical procedure suited for the operating room.
- Prof. Dr. Marion KiechleDirector of the Women’s Hospital Klinikum rechts der Isar Munich, GermanyThe declipse®SPECT technology and its intraoperative use for navigated sentinel lymph node dissection enables safer surgeries, and less invasive procedures. This can ensure a high quality outcome for every individual patient.
- Dr. Omgo E. NiewegSurgeon, The Netherlands Cancer Institute Amsterdam, the NetherlandsThe innovative 3D declipseSPECT technology may make the sentinel node biopsy easier and more reliable. New technologies like 3D declipseSPECT will also open up lymphatic mapping to additional cancer types in locations with a more intricate anatomy and cancer types with more complex lymph drainage.